Novavax Company Profile (NASDAQ:NVAX)

About Novavax

Novavax logoNovavax, Inc. (Novavax) is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company through its recombinant nanoparticle vaccine technology produces vaccine candidates to respond to both known and newly emerging diseases. Its product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). Its lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NVAX
  • CUSIP: 67000210
Key Metrics:
  • Previous Close: $7.18
  • 50 Day Moving Average: $7.35
  • 200 Day Moving Average: $5.99
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.33
  • P/E Growth: 0.00
  • Market Cap: $1.94B
  • Outstanding Shares: 270,834,000
  • Beta: 1.35
Additional Links:
Companies Related to Novavax:

Analyst Ratings

Consensus Ratings for Novavax (NASDAQ:NVAX) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $12.46 (73.51% upside)

Analysts' Ratings History for Novavax (NASDAQ:NVAX)
Show:
DateFirmActionRatingPrice TargetDetails
8/14/2016Chardan CapitalReiterated RatingHold$5.75View Rating Details
8/11/2016FBR & CoSet Price TargetBuy$17.00View Rating Details
7/28/2016Citigroup Inc.Boost Price TargetBuy$10.00 -> $12.00View Rating Details
7/27/2016WedbushReiterated RatingOutperform$14.00View Rating Details
6/29/2016Piper Jaffray Cos.Reiterated RatingOverweight$14.00View Rating Details
3/3/2016JPMorgan Chase & Co.Lower Price TargetOverweight$14.00 -> $12.00View Rating Details
8/3/2015GuggenheimInitiated CoverageMarket Perform$17.00View Rating Details
8/2/2015Ladenburg ThalmannReiterated RatingBuyView Rating Details
4/7/2015Janney Montgomery ScottReiterated Rating$12.00View Rating Details
2/12/2015GMP SecuritiesInitiated CoveragePositiveView Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Novavax (NASDAQ:NVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.25)($0.29)$8.03 million$2.50 millionViewListenView Earnings Details
5/4/2016Q1($0.27)($0.29)$10.39 million$4.20 millionViewListenView Earnings Details
2/29/2016Q415($0.14)($0.29)$8.07 million$5.90 millionViewListenView Earnings Details
11/9/2015Q315($0.09)($0.12)$10.59 million$6.50 millionViewN/AView Earnings Details
8/10/2015Q215($0.09)($0.08)$9.90 million$14.00 millionViewListenView Earnings Details
5/7/2015Q115($0.11)($0.10)$9.70 million$9.88 millionViewN/AView Earnings Details
2/26/2015Q4 14($0.08)($0.13)$9.60 million$6.70 millionViewN/AView Earnings Details
11/5/2014Q314($0.07)($0.08)$9.20 million$8.20 millionViewN/AView Earnings Details
8/6/2014Q214($0.07)($0.08)$8.74 million$8.26 millionViewN/AView Earnings Details
5/7/2014Q114($0.07)($0.07)$3.80 million$7.50 millionViewN/AView Earnings Details
3/10/2014Q413($0.08)($0.07)$6.22 million$8.70 millionViewN/AView Earnings Details
11/7/2013Q313($0.06)($0.09)$4.56 million$4.80 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.06)($0.08)$4.45 million$3.50 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.06)($0.07)$5.54 million$3.80 millionViewN/AView Earnings Details
3/1/2013Q4 2012($0.04)($0.06)$5.85 million$4.57 millionViewN/AView Earnings Details
11/2/2012Q312($0.05)($0.05)$7.59 million$5.80 millionViewN/AView Earnings Details
8/3/2012($0.07)($0.05)ViewN/AView Earnings Details
5/4/2012($0.04)($0.06)ViewN/AView Earnings Details
3/9/2012($0.04)($0.03)ViewN/AView Earnings Details
11/4/2011($0.06)($0.03)ViewN/AView Earnings Details
8/5/2011($0.08)($0.04)ViewN/AView Earnings Details
5/9/2011($0.07)($0.07)ViewN/AView Earnings Details
3/28/2011($0.09)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novavax (NASDAQ:NVAX)
Current Year EPS Consensus Estimate: $-1.07 EPS
Next Year EPS Consensus Estimate: $-0.98 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.27)($0.13)($0.22)
Q2 20163($0.28)($0.13)($0.19)
Q3 20162($0.27)($0.24)($0.26)
Q4 20162($0.26)($0.24)($0.25)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.25)($0.25)($0.25)
Q3 20171($0.24)($0.24)($0.24)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Novavax (NASDAQ:NVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novavax (NASDAQ:NVAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2016Barclay A. PhillipsCFOBuy422$4.29$1,810.38View SEC Filing  
6/6/2016Gary C EvansDirectorSell18,998$6.50$123,487.00View SEC Filing  
5/24/2016Gary C EvansDirectorSell50,000$5.41$270,500.00View SEC Filing  
3/31/2016Stanley C ErckCEOSell424,778$5.19$2,204,597.82View SEC Filing  
1/31/2016Barclay A. PhillipsCFOBuy405$4.38$1,773.90View SEC Filing  
1/31/2016Gregory M. GlennSVPBuy2,369$4.38$10,376.22View SEC Filing  
1/31/2016Stanley C. ErckCEOBuy2,072$4.38$9,075.36View SEC Filing  
12/16/2015John A Herrmann IIISVPSell27,945$8.64$241,444.80View SEC Filing  
8/24/2015Gary C EvansDirectorSell20,000$11.24$224,800.00View SEC Filing  
8/20/2015Barclay A. PhillipsCFOSell28,656$13.06$374,247.36View SEC Filing  
8/18/2015Gregory M. GlennSVPSell15,000$13.52$202,800.00View SEC Filing  
8/13/2015Gary C EvansDirectorSell6,002$13.56$81,387.12View SEC Filing  
6/18/2015James F YoungDirectorSell50,000$9.47$473,500.00View SEC Filing  
6/17/2015Rajiv I ModiDirectorSell433,053$9.01$3,901,807.53View SEC Filing  
6/11/2015Rajiv I ModiDirectorSell11,185$9.00$100,665.00View SEC Filing  
6/10/2015Rajiv I ModiDirectorSell551,081$8.97$4,943,196.57View SEC Filing  
6/9/2015Rajiv I ModiDirectorSell47,531$8.93$424,451.83View SEC Filing  
6/8/2015Rajiv I ModiDirectorSell206,175$8.93$1,841,142.75View SEC Filing  
6/4/2015Rajiv I ModiDirectorSell504,681$8.92$4,501,754.52View SEC Filing  
6/1/2015Rajiv I ModiDirectorSell3,500,000$8.74$30,590,000.00View SEC Filing  
1/31/2015Barclay A PhillipsCFOBuy8,388$2.28$19,124.64View SEC Filing  
1/31/2015John TrizzinoSVPBuy6,611$3.63$23,997.93View SEC Filing  
1/31/2015Stanley C ErckCEOBuy6,122$2.28$13,958.16View SEC Filing  
12/16/2014Gary C EvansDirectorSell46,701$5.72$267,129.72View SEC Filing  
12/12/2014Gary C EvansDirectorSell30,000$5.77$173,100.00View SEC Filing  
11/20/2014Rajiv I ModiDirectorSell518,889$5.02$2,604,822.78View SEC Filing  
11/18/2014Rajiv I ModiDirectorSell1,481,111$5.00$7,405,555.00View SEC Filing  
10/3/2014Barclay A PhillipsCFOBuy5,000$4.11$20,550.00View SEC Filing  
10/3/2014Timothy Jon HahnSVPBuy2,500$4.05$10,125.00View SEC Filing  
9/26/2014Gregory M GlennSVPSell16,809$4.16$69,925.44View SEC Filing  
9/25/2014Timothy Jon HahnSVPBuy9,000$4.17$37,530.00View SEC Filing  
7/31/2014Barclay A PhillipsCFOBuy8,788$2.28$20,036.64View SEC Filing  
7/31/2014Russell P WilsonSVPBuy4,989$2.28$11,374.92View SEC Filing  
7/31/2014Stanley C ErckCEOBuy6,788$2.28$15,476.64View SEC Filing  
6/17/2014John TrizzinoSVPBuy5,500$4.51$24,805.00View SEC Filing  
6/16/2014John TrizzinoSVPBuy16,500$4.51$74,415.00View SEC Filing  
3/25/2014Barclay PhillipsCFOBuy5,000$4.25$21,250.00View SEC Filing  
3/25/2014Richard DouglasDirectorBuy50,000$4.33$216,500.00View SEC Filing  
3/25/2014Stanley ErckCEOBuy10,000$4.27$42,700.00View SEC Filing  
3/21/2014Pharmaceuticals Ltd Cadilamajor shareholderSell3,000,000$4.95$14,850,000.00View SEC Filing  
1/31/2014Barclay PhillipsCFOBuy9,868$2.29$22,597.72View SEC Filing  
1/31/2014Stanley ErckCEOBuy11,868$2.29$27,177.72View SEC Filing  
1/31/2014Timothy Jon HahnSVPBuy9,416$2.29$21,562.64View SEC Filing  
6/12/2013Richard DouglasDirectorBuy50,000$1.90$95,000.00View SEC Filing  
6/10/2013Timothy Jon HahnSVPBuy21,000$1.88$39,480.00View SEC Filing  
6/7/2013Gregory M GlennInsiderBuy2,000$1.92$3,840.00View SEC Filing  
6/6/2013James F YoungDirectorBuy100,000$1.91$191,000.00View SEC Filing  
3/11/2013James F YoungDirectorBuy100,000$2.03$203,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Novavax (NASDAQ:NVAX)
DateHeadline
fool.com logoBillionaire George Soros' Fund Dumped These 3 Biotech Holdings. Should You? (NASDAQ:NVAX)
www.fool.com - August 28 at 8:42 AM
mysmartrend.com logoUptrend Call Working As Novavax Stock Rises 30.8% (NVAX) (NASDAQ:NVAX)
www.mysmartrend.com - August 27 at 10:50 AM
News IconNovavax Shares To Skyrocket Post Phase 3 Resolve Trial Results: Guggenheim (NASDAQ:NVAX)
mrtopstep.com - August 27 at 10:49 AM
smarteranalyst.com logoGuggenheim Pounds the Table on Novavax, Inc. (NVAX) (NASDAQ:NVAX)
www.smarteranalyst.com - August 27 at 10:49 AM
smarteranalyst.com logoGuggenheim Pounds the Table on Novavax, Inc. (NVAX) - Smarter Analyst (NASDAQ:NVAX)
www.smarteranalyst.com - August 26 at 6:17 PM
News IconHC Stocks Review: Novavax, Inc. (NVAX), Skyline Medical Inc (SKLN) - share market updates (press release) (NASDAQ:NVAX)
sharemarketupdates.com - August 25 at 11:39 AM
News IconBiotech news that matter for investors: Novavax, Inc. (NASDAQ:NVAX), MannKind Corp. (NASDAQ:MNKD) - The Voice Registrar (NASDAQ:NVAX)
voiceregistrar.com - August 25 at 11:39 AM
finance.yahoo.com logoThis Small-Cap Vaccine Company Offers 14.5% Upisde, Vetr Crowd Says (NASDAQ:NVAX)
finance.yahoo.com - August 24 at 6:16 PM
capitalcube.com logoNovavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : August 24, 2016 (NASDAQ:NVAX)
www.capitalcube.com - August 24 at 9:40 AM
capitalcube.com logoETF’s with exposure to Novavax, Inc. : August 23, 2016 (NASDAQ:NVAX)
www.capitalcube.com - August 23 at 6:44 PM
nasdaq.com logoInteresting NVAX Put And Call Options For April 2017 (NASDAQ:NVAX)
www.nasdaq.com - August 22 at 6:31 PM
investornewswire.com logoCan Novavax, Inc. (NASDAQ:NVAX) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:NVAX)
www.investornewswire.com - August 22 at 11:08 AM
News IconWorth Watching Stocks: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Novavax, Inc. (NASDAQ:NVAX) - Post Registrar (NASDAQ:NVAX)
postregistrar.com - August 22 at 11:08 AM
News IconResearch Report on Biotech Equities -- Gilead Sciences, Exelixis, Ariad Pharma, and Novavax (NASDAQ:NVAX)
www.kait8.com - August 19 at 9:35 AM
4-traders.com logoNovavax : Research Report on Biotech Equities -- Gilead Sciences, Exelixis, Ariad Pharma, and Novavax (NASDAQ:NVAX)
www.4-traders.com - August 19 at 9:35 AM
mysmartrend.com logoNovavax Has Returned 32.0% Since SmarTrend Recommendation (NVAX) (NASDAQ:NVAX)
www.mysmartrend.com - August 19 at 9:35 AM
News IconThe Key Numbers To Watch From Novavax, Inc. (NASDAQ:NVAX)'s ... - The Voice Registrar (NASDAQ:NVAX)
voiceregistrar.com - August 18 at 6:41 PM
finance.yahoo.com logoNOVAVAX INC Financials (NASDAQ:NVAX)
finance.yahoo.com - August 18 at 6:41 PM
News IconHC Stocks Review: Novavax, Inc. (NASDAQ:NVAX), Skyline Medical Inc (NASDAQ:SKLN) - share market updates (press release) (NASDAQ:NVAX)
sharemarketupdates.com - August 18 at 9:39 AM
fool.com logoBetter Buy: Novavax, Inc. vs. Inovio Pharmaceuticals (NASDAQ:NVAX)
www.fool.com - August 15 at 6:53 PM
mysmartrend.com logoNovavax Up 26.5% Since SmarTrend Uptrend Call (NVAX) (NASDAQ:NVAX)
www.mysmartrend.com - August 12 at 6:39 PM
capitalcube.com logoNovavax, Inc. :NVAX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:NVAX)
www.capitalcube.com - August 12 at 6:39 PM
capitalcube.com logoETF’s with exposure to Novavax, Inc. : August 12, 2016 (NASDAQ:NVAX)
www.capitalcube.com - August 12 at 6:39 PM
investorplace.com logoNovavax, Inc.: NVAX Stock Gets Gutted — Can It Still Double? (NASDAQ:NVAX)
investorplace.com - August 11 at 9:47 AM
biz.yahoo.com logoNOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:NVAX)
biz.yahoo.com - August 11 at 9:46 AM
barrons.com logo[$$] Novavax Vaccine May Be Game Changer (NASDAQ:NVAX)
www.barrons.com - August 11 at 9:46 AM
capitalcube.com logoNovavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : August 11, 2016 (NASDAQ:NVAX)
www.capitalcube.com - August 11 at 9:46 AM
News IconBrokerage Recom. Worth Watching: Novavax, Inc. (NASDAQ:NVAX) - The Voice Registrar (NASDAQ:NVAX)
voiceregistrar.com - August 10 at 7:00 PM
News IconValeant Pharmaceuticals Intl (NYSE:VRX) & Novavax, Inc. (NASDAQ:NVAX) News Review - Money News (press release) (NASDAQ:NVAX)
www.newsismoney.com - August 10 at 7:00 PM
investorplace.com logoNovavax, Inc.: NVAX Stock Gets Gutted — Can It Still Double? - Investorplace.com (NASDAQ:NVAX)
investorplace.com - August 10 at 7:00 PM
thestreet.com logoNovavax (NVAX) Stock Dropping as Q2 Results Miss Expectations (NASDAQ:NVAX)
www.thestreet.com - August 10 at 7:00 PM
finance.yahoo.com logoEdited Transcript of NVAX earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:NVAX)
finance.yahoo.com - August 10 at 7:00 PM
investorplace.com logoNovavax, Inc.: NVAX Stock Gets Gutted — Can It Still Double? (NASDAQ:NVAX)
investorplace.com - August 10 at 1:06 PM
smarteranalyst.com logoCompany Update (NASDAQ:NVAX): Novavax, Inc. Reports Second Quarter 2016 Financial Results (NASDAQ:NVAX)
www.smarteranalyst.com - August 10 at 9:39 AM
rttnews.com logoEARNINGS SUMMARY: Details of Novavax Inc. Q2 Earnings Report (NASDAQ:NVAX)
www.rttnews.com - August 9 at 6:48 PM
ft.com logoNovavax Reports Second Quarter 2016 Financial Results (NASDAQ:NVAX)
announce.ft.com - August 9 at 6:48 PM
twst.com logoNovavax Inc.: Novavax Reports Second Quarter 2016 Financial Results – (NASDAQ:NVAX)
www.twst.com - August 9 at 6:48 PM
sg.finance.yahoo.com logoNovavax reports 2Q loss (NASDAQ:NVAX)
sg.finance.yahoo.com - August 9 at 6:48 PM
thestreet.com logoHow Will Novavax (NVAX) Stock React After Q2 Miss? (NASDAQ:NVAX)
www.thestreet.com - August 9 at 6:48 PM
fortune.com logoAnalyst Recommendations On Watch List: Novavax, Inc. (NASDAQ:NVAX), Juniper Networks, Inc. (NYSE:JNPR) - Review Fortune (NASDAQ:NVAX)
reviewfortune.com - August 9 at 9:43 AM
biz.yahoo.com logoQ2 2016 Novavax Inc Earnings Release - After Market Close (NASDAQ:NVAX)
biz.yahoo.com - August 9 at 9:43 AM
News IconTop Earnings to Watch for: Novavax, Inc. (NASDAQ:NVAX) - The Voice Registrar (NASDAQ:NVAX)
voiceregistrar.com - August 5 at 6:45 PM
streetupdates.com logoAnalysts Watching Stocks Update: Exelixis, Inc. (NASDAQ:EXEL) , Novavax, Inc. (NASDAQ:NVAX) - Street Updates (NASDAQ:NVAX)
www.streetupdates.com - August 5 at 6:45 PM
News IconEquity Research Analyst's Stock Ratings: Novavax, Inc. (NASDAQ:NVAX), Freeport-McMoRan Inc. (NYSE:FCX) - TWN (NASDAQ:NVAX)
thewellesleysnews.com - August 5 at 6:45 PM
equities.com logoNovavax Inc. (NVAX) Jumps 5.84% on August 03 - Equities.com (NASDAQ:NVAX)
www.equities.com - August 4 at 6:57 PM
News IconHot Biotech Stocks Recap: CytRx Corporation (NASDAQ:CYTR), Novavax, Inc. (NASDAQ:NVAX) - The Voice Registrar (NASDAQ:NVAX)
voiceregistrar.com - August 4 at 9:43 AM
News IconAnalyst Stock Ratings: Novavax, Inc. (NASDAQ:NVAX), Diamondrock Hospitality Co. (NYSE:DRH) - The Wellesleys News (NASDAQ:NVAX)
thewellesleysnews.com - August 3 at 9:48 AM
finance.yahoo.com logoNovavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016 (NASDAQ:NVAX)
finance.yahoo.com - August 2 at 6:51 PM
publicnow.com logoNovavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016 - (NASDAQ:NVAX)
www.publicnow.com - August 2 at 6:51 PM
istreetwire.com logoStocks In Queue: NetSuite Inc. (N), Novavax, Inc. (NVAX), BioTelemetry, Inc. (BEAT) (NASDAQ:NVAX)
istreetwire.com - August 1 at 11:12 AM

Social

Novavax (NASDAQ:NVAX) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff